IRIDEX Corporation (IRIX)
NASDAQ: IRIX · IEX Real-Time Price · USD
2.850
+0.010 (0.35%)
May 2, 2024, 10:42 AM EDT - Market open
IRIDEX Revenue
In the year 2023, IRIDEX had annual revenue of $51.87M, a decrease of -8.96%. Revenue in the quarter ending December 30, 2023 was $12.46M, a -18.01% decrease year-over-year.
Revenue (ttm)
$51.87M
Revenue Growth
-8.96%
P/S Ratio
0.88
Revenue / Employee
$467,288
Employees
111
Market Cap
46.32M USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 30, 2023 | 51.87M | -5.10M | -8.96% |
Dec 31, 2022 | 56.97M | 3.07M | 5.69% |
Jan 1, 2022 | 53.90M | 17.56M | 48.30% |
Jan 2, 2021 | 36.35M | -7.10M | -16.34% |
Dec 28, 2019 | 43.45M | 847.00K | 1.99% |
Dec 29, 2018 | 42.60M | 1.01M | 2.42% |
Dec 30, 2017 | 41.59M | -4.57M | -9.89% |
Dec 31, 2016 | 46.16M | 4.40M | 10.54% |
Jan 2, 2016 | 41.76M | -1.06M | -2.47% |
Jan 3, 2015 | 42.81M | 4.54M | 11.86% |
Dec 28, 2013 | 38.27M | 4.41M | 13.04% |
Dec 29, 2012 | 33.86M | 700.00K | 2.11% |
Dec 31, 2011 | 33.16M | 851.00K | 2.63% |
Jan 1, 2011 | 32.31M | 1.28M | 4.11% |
Jan 2, 2010 | 31.03M | -17.50M | -36.05% |
Jan 3, 2009 | 48.53M | -7.00M | -12.61% |
Dec 29, 2007 | 55.53M | 19.63M | 54.67% |
Dec 30, 2006 | 35.90M | -1.13M | -3.04% |
Dec 31, 2005 | 37.03M | 4.22M | 12.86% |
Jan 1, 2005 | 32.81M | - | - |
Jan 3, 2004 | 32.81M | 2.18M | 7.10% |
Dec 28, 2002 | 30.63M | 3.36M | 12.32% |
Dec 29, 2001 | 27.28M | -5.56M | -16.94% |
Dec 30, 2000 | 32.84M | 6.45M | 24.43% |
Jan 1, 2000 | 26.39M | 2.75M | 11.62% |
Jan 2, 1999 | 23.64M | 5.57M | 30.82% |
Dec 31, 1997 | 18.07M | 5.71M | 46.17% |
Dec 31, 1996 | 12.36M | 3.56M | 40.48% |
Dec 31, 1995 | 8.80M | 1.62M | 22.54% |
Dec 31, 1994 | 7.18M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
American Oncology Network | 1.28B |
Cutera | 230.18M |
Apyx Medical | 52.35M |
Daxor | 34.67M |
Aadi Bioscience | 24.35M |
Milestone Scientific | 9.83M |
Matinas BioPharma Holdings | 1.10M |
Clene | 654.00K |
IRIX News
- 5 weeks ago - Iridex Reports Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 6 weeks ago - Iridex Schedules Fourth Quarter and Full Year 2023 Financial Results and Update on Strategic Review Process for March 26, 2024 - GlobeNewsWire
- 3 months ago - Iridex Announces First Patient Enrollment in MicroPulse® TLT Clinical Study Conducted in Collaboration with Imperial College Healthcare NHS Trust - GlobeNewsWire
- 3 months ago - Iridex Launches New Iridex 532® and Iridex 577® Lasers in US Market Marking 35 Years of Laser Innovation in Treating Retina Disorders & Glaucoma - GlobeNewsWire
- 4 months ago - Iridex Confirms Medicare Administrative Contractors Retired Local Coverage Determinations that Restricted Cyclophotocoagulation - GlobeNewsWire
- 5 months ago - Iridex Corporation Announces Successful Appeal for Revision of Recent Medicare LCDs to Provide Broader Coverage of Cyclophotocoagulation - GlobeNewsWire
- 6 months ago - Iridex Reports Third Quarter 2023 Financial Results and Business Update - GlobeNewsWire
- 6 months ago - Iridex to Host Third Quarter Financial Results Conference Call on November 14, 2023 - GlobeNewsWire